|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/20 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| G01N 33/574 |
| (11) | Number of the document | 2435068 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10781290.1 |
| Date of filing the European patent application | 2010-05-28 | |
| (97) | Date of publication of the European application | 2012-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/036615 |
| Date | 2010-05-28 |
| (87) | Number | WO 2010/138839 |
| Date | 2010-12-02 |
| (30) | Number | Date | Country code |
| 182081 P | 2009-05-28 | US |
| (72) |
TRIEU, Vuong, US
DESAI, Neil, US
KNAUER, Daniel, US
|
| (73) |
Abraxis BioScience, LLC,
11755 Wilshire Boulevard, Los Angeles, CA 90025,
US
|
| (54) | USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY |
| USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY |